Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03246308
Other study ID # 1462/2017
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 8, 2017
Est. completion date May 1, 2019

Study information

Verified date May 2019
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Research project in which blood samples of patients undergoing UVB phototherapy for the treatment of different cutaneous diseases will be investigated for changes of folate levels and further vitamins over the course of treatment.


Description:

UVB phototherapy is used to treat a plethora of different dermatoses with a favorable side effect profile compared to systemic alternatives. One rarely mentioned issue related to phototherapy is the question of whether it holds potential to decrease folate serum levels, which is of particular interest to women of childbearing age, as birth defects, such as neural tube defects (NTD), cardiac defects, and facial clefting have all been noted to be increased in women with folate deficiency. Several studies, involving different patient groups and modes of phototherapy, have investigated the changes of folate levels throughout therapy showing mixed results. While two small open studies from Egypt showed a significant reduction of folate levels after 24 and 18 / 36 exposures (1-2), several other studies failed to show a significant change (3-6). In addition, there are also conflicting data on the influence of UVB phototherapy on vitamin D, vitamin B12 and homocysteine levels. Therefore, the presented prospective trial aims at investigating the changes of these vitamins during a routine course of phototherapy. The study will focus on the following specific aims: Measure the levels of folate as well as the levels of further vitamin parameters (including homocysteine, 25-OH-vitamin D3, 1,25-OH-vitamin D3, holotranscobalamin and methylmalonic acid) before and during phototherapy (at baseline, after 12, 24 and 36 exposures and/or at the end of treatment)


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date May 1, 2019
Est. primary completion date May 1, 2019
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients undergoing UVB phototherapy (narrowband UVB or broadband UVB)

- Male and female participants minimum 18 years old

- Written informed consent by the participant after information about the research project

Exclusion Criteria:

- Regular sunbed use

- Underlying disease with abnormal folate metabolism (e.g. thalassemia)

- Age below 18 years

- Patients who will not be able to attend regularly for treatment

Study Design


Related Conditions & MeSH terms


Intervention

Radiation:
Phototherapy
Taking blood sample.

Locations

Country Name City State
Austria Medical University of Vienna Vienna

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Folate level The change of the folate levels will be measured at baseline and at the end of phototherapy. 3 years
Primary vitamin D level The change of vitamin D levels will be measured at baseline and at the end of phototherapy. 3 years
See also
  Status Clinical Trial Phase
Completed NCT05739058 - Violet-Blue Light Inactivation of Bacteria in Chronic Wounds N/A
Completed NCT06386731 - Continuous Versus Intermittent Phototherapy in Treatment of Neonatal Jaundice N/A
Completed NCT04373980 - Conventional Versus LED Phototherapy and Their Effect on Lymphocytes Subsets of Full Term Neonates With Hyperbilirubinemia N/A
Active, not recruiting NCT03074292 - Comparison Between Effect of Conventional, Intensive and Light Emitting Diodes (LED) Phototherapy on Oxidative Stress Among Neonates With Unconjugated Hyperbilirubinemia N/A